Venous thromboembolism (VTE) is the third most common cause of vascular mortality
worldwide and comprises deep-vein thrombosis (DVT) and pulmonary embolism (PE). In …

Venous thromboembolism (VTE) is the third most common cause of death worldwide. The
incidence of VTE varies according to different countries, ranging from 1–2 per 1000 person …

Coronavirus disease 2019 (COVID-19) has caused a global pandemic in just a few months,
causing millions infected. Nearly 20% of COVID-19 patients present severe coagulation …

Background Venous thromboembolism (VTE) is frequently observed in patients with
coronavirus disease 2019 (COVID‐19). However, reported VTE rates differ substantially …

BACKGROUND Emerging evidence shows that severe COVID-19 can be complicated by a
significant coagulopathy, that likely manifests in the form of both microthrombosis and …

AIMS OF THE STUDY Many centres have noticed a high number of venous
thromboembolism (VTE) events among critically ill inpatients with COVID-19 pneumonia …

Comment www. thelancet. com/haematology Vol 7 May 2020 e363 risk factors (aged 40
years or older, had hepatic failure (international normalised ratio> 1∙ 5), had severe renal …

Essentials• Venous thromboembolism (VTE) is among the three main causes of
cardiovascular disease worldwide.• This review is the first to summarize the epidemiology of …

Background: Preliminary evidence indicates that prophylactic-dose thromboprophylaxis may
be inadequate to control the increased risk of venous thromboembolism (VTE) in patients …

Background Venous thromboembolism (VTE) is the third most common cardiovascular
condition, after myocardial infarction and stroke. Prophylactic measures in accordance with …